Cargando…

Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis

Resting tumor cells represent a huge challenge during anticancer therapy due to their increased treatment resistance. TNF-related apoptosis-inducing ligand (TRAIL) is a putative future anticancer drug, currently in phases I and II clinical studies. We recently showed that TRAIL is able to target leu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrhardt, H, Wachter, F, Grunert, M, Jeremias, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698546/
https://www.ncbi.nlm.nih.gov/pubmed/23744361
http://dx.doi.org/10.1038/cddis.2013.179

Ejemplares similares